article thumbnail

Review of 505(b)(2) Drug Products Approved by USFDA from 2010 to 2020: A Focus on Intellectual Property and Regulatory Considerations

Drug Patent Watch

A review article in the Journal of Pharmaceutical Sciences analyzes the trends in drug repurposing through the 505(b)(2) pathway, as approved by the USFDA from 2010 to 2020.

75
article thumbnail

2020 OPDP Enforcement

Eye on FDA

Looking now to a review of enforcement by the Office of Prescription Drug Promotion (OPDP) in 2020, we see a different picture. The collection of letters issued by OPDP during 2020 can be found here. The article states that the program had received over 2000 reports over its lifetime. So when OPDP did act, they meant business.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

5 ways digital health, and digital pharma, changed in 2020

pharmaphorum

But that was before the first reports emerged of a highly contagious coronavirus and 2020 will be forever associated with COVID-19 and the global devastation and disruption it has wrought. In fact, preparing for our year in review articles, we decided in our editorial meeting to have at least one look at medical progress away from COVID.

article thumbnail

The Themes of The World Pharmacists Day 2010-2020

Pharma Mirror

The post The Themes of The World Pharmacists Day 2010-2020 appeared first on Pharma Mirror Magazine. World Pharmacist Day is celebrated on 25th September every year since 2010 on the day FIP (International Pharmaceutical Federation) started their journey.

97
article thumbnail

Big Decisions – Reviewing FDA Advisory Committee Outcomes Since 2020

Eye on FDA

That said, beginning in 2020 meetings began skewing to more negative outcomes and 2022 was the first year where the number of negative outcomes outweighed the number of positive outcomes. There are a lot of variables that factor in. As noted earlier, this coincides with the transition to virtual meetings over in-person ones. in mid-February.

article thumbnail

Artificial Intelligence Wrote Most of This Article

Pulses

and I have written an entire article about it. 2020; 27(5):284-324. By : Jeff Cain, EdD, MS As of 7:00 this morning, I only had a cursory knowledge of how artificial intelligence (AI) might play a role in the scholarly aspects of pharmacy education. It is now 7:31 a.m. I used Jasper , an AI writing assistant to generate the rest of it.

article thumbnail

The State of Specialty Pharmacy in 2020 (video)

Drug Channels

I'll be back with a new article next week. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. In this clip, I highlight the growth and consolidation dynamics facing the specialty pharmacy industry. I also discuss the competitive challenges facing smaller pharmacies. Never fear, Drug Channels traditionalists.